The Sant’Orsola-Malpighi Polyclinic is a university and public hospital. The Polyclinc is the largest hospital in Italy, and the first of the four public hospitals of the city of Bologna. The Polyclinic has approximately 1,535 beds and 5,153 employees.

There are 1,535 beds in Institute Of Hematology "Seràgnoli".

During the past decade, Institute Of Hematology "Seràgnoli" conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institute Of Hematology "Seràgnoli"" are "Acute Lymphoblastic Leukemia" (1 trials), "Adult" (1 trials), "Anemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Diffuse Large B Cell Lymphoma" (1 trials). Many other conditions were trialed in "Institute Of Hematology "Seràgnoli"" in a lesser frequency.

Most popular intervention types in "Institute Of Hematology "Seràgnoli"" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gut microbiota samples" (1 trials), "INCB000928" (1 trials), "Lenalidomide" (1 trials), "Lenalidomide plus Rituximab" (1 trials) and "doxorubicin liposomal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute Of Hematology "Seràgnoli"" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Institute Of Hematology "Seràgnoli"". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute Of Hematology "Seràgnoli", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute Of Hematology "Seràgnoli", 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".